New DNA vaccine aims to stop liver cancer recurrence after surgery
Disease control
Recruiting now
This study tests a DNA vaccine called NWRD06 in 30 adults with a type of liver cancer (hepatocellular carcinoma) that has been surgically removed. The vaccine targets a protein called GPC3 found on cancer cells, aiming to train the immune system to destroy any remaining cancer ce…
Phase: PHASE2 • Sponsor: Newish Technology (Beijing) Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:40 UTC